Adrenocorticotropic hormone response to hypoglycemic stress was preserved by a single bedtime 3-mg dose of prednisolone in patients with rheumatoid arthritis

Modern Rheumatology

Volumn 14, Issue 4, 2004, Pages 291-295

  Kuroki, Yasuo ^a   Takabayashi, Chihiro ^b   Nishiyama, Katsuhito ^a   Shimada, Takao ^a   Shiozawa, Shunichi ^b   Chihara, Kazuo ^b   Ueba, Yasuyuki ^a  

^a Kanebo Memorial Hospital   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenocorticotropic hormone (ACTH) response; Depression; Hypothalamic pituitary adrenal (HPA) axis; Low dose prednisolone; Rheumatoid arthritis (RA)

Indexed keywords

ACTARIT; BUCILLAMINE; CORTICOTROPIN; HYDROCORTISONE; INSULIN; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ACTIVITY; DOSE RESPONSE; FUNCTIONAL ASSESSMENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN TOLERANCE TEST; LOW DRUG DOSE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SELF REPORT; SINGLE DRUG DOSE; SLEEP; STRESS; SYMPTOMATOLOGY; VISUAL ANALOG SCALE;

EID: 20444375128     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-004-0311-8     Document Type: Article

References (32)

1. Potter PT, Zautra AJ. Stressful life events' effects on rheumatoid arthritis disease activity. J Consulting Clin Psychol 1997;65:319-23.
2. Affleck G, Pfeiffer C, Tennen H, Fifield J. Attributional processes in rheumatoid arthritis patients. Arthritis Rheum 1987;30:927-31.
3. Zautra AJ, Burleson MH, Matt KS, Roth S, Burrows LD. Interpersonal stress, depression, hormones, and disease activity in rheumatoid arthritis and osteoarthritis patients. Health Psychology 1994;13:139-48.
4. Parker JC, Wright GE. The implications of depression for pain and disability in rheumatoid arthritis. Arthritis Care Res 1995;8:279-82.
5. Frank RG, Beck NC, Parker JC, Kashani JH, Elliott TR, Haut AE, et al. Depression in rheumatoid arthritis. J Rheumatol 1988;15: 920-5.
6. Katz PP, Yelin EH. Prevalence and correlates of depression symptoms among persons with rheumatoid arthritis. J Rheumatol 1993;20:790-6.
7. Wolfe F, Hawley DJ. The relationship between clinical activity and depression in rheumatoid arthritis. J Rheumatol 1993;20:2032-7.
8. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress (1). N Eng J Med 1988;319:348-58.
9. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999;160:1-12.
10. Nemeroff CB. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions. Mol Psychiatry 1996;1:336-42.
11. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Eng J Med 1995;332:1351-62.
12. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med 1992;117:854-66.
13. Hall J, Morand EF, Medbank S, Zaman M, Perrry S, Nicolas J, et al. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Arthritis Rheum 1994;37:1132-7.
14. Templ E, Koeller M, Riedl M, Wagner O, Graniger W, Luger A. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br J Rheumatol 1996;35:350-6.
15. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi S. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;11:1281-8.
16. Myles AB, Schiller LFG, Glass D, Dary JR. Single daily dose corticosteroid treatment. Ann Rheum Dis 1976;35:73-6.
17. Kuroki Y, Iwakura H, Morita R, Suemitsu N. Chronopharmacological administration of prednisolone to patients with rheumatoid arthritis (in Japanese). Ryumachi 1999;39:328.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
20. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.
21. Zung WWK. Self-rating depression scale. Arch Gen Psychiat 1965;12:63-70.
22. Fukuda I, Kobayashi S. A study on a self-rating depression scale (in Japanese). Seishin Shinkeigaku Zasshi 1973;75:673-9.
23. Demir H, Kelstimur F, Tunc M, Kirnup M, Ozugul Y. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand J Rheumatol 1999;2841-6.
24. Bertolini A, Poggioli R, Vergoni AV. Cross-species comparison of the ACTH-induced behavioral syndrome. Ann NY Acad Sci 1988;525:114-29.
25. Plotsky PM. Regulation of hypophysiotropic factors mediating ACTH secretion. Ann NY Acad Sci 1987;512:205-17.
26. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Eng J Med 1995;333:142-6.
27. Everdingen AA, Jacobs JW, Reesema DS, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects. Ann Intern Med 2000;136:1-12.
28. Klinefelter HF, Walter L, Bledsoe T. Single daily dose prednisolone therapy. JAMA 1979;241:2721-3.
29. Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001;49:391-404.
30. Spencer RL, Kim PJ, Kalman BA, Cole MA. Evidence for mineral corticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 1998;139:2718-26.
31. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrinol Rev 2000;21:55-89.
32. Neeck G, Federlin K, Graef V, Rusch G, Schmidt KL. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Reumatol 1990;17:24-9.